With the U.S. Within Months of the First Covid-19 Vaccine Approval, What’s Next?
By Amit Kumar, Ph.D., CEO of Anixa Biosciences
Latest News & Events
Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference
Read More...Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds
Read More...Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
Read More...